Parenteral Nutrition Market (By Nutrient Type: Carbohydrates, Parenteral Lipid Emulsion, Single Dose Amino Acid Solution, Trace Elements, Vitamins & Minerals; By Stage Type: Adult, Pediatrics; By Indication: Alzheimer’s, Nutrition Deficiency, Cancer Care, Diabetes, Chronic Kidney Diseases, Orphan Diseases, Dysphagia, Pain Management, Malabsorption/GI Disorder/Diarrhea, Others; By Sales Channel; By Region: North America, LAMEA, Europe, Asia-Pacific) Industry Size, Share, Growth, Trends 2026 to 2035.
The global parenteral nutrition market, valued at USD 8.01 billion in 2025, is projected to reach USD 14.32 billion by 2035, expanding at a CAGR of 5.98%, driven by rising chronic disease prevalence, advanced clinical nutrition solutions, and growing demand for critical care support.
| Reports Attributes | Statistics |
| Market Size in 2025 | USD 8.01 Billion |
| Market Size in 2026 | USD 8.49 Billion |
| Market Size in 2032 | USD 12.03 Billion |
| Market Size by 2035 | USD 14.32 Billion |
| CAGR 2026 to 2035 | 5.98% |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
The extremity of malnutrition and metabolic necessities is introducing valuable macronutrients in this market. The rising cases of crucial conditions like sepsis, burns, or trauma, leaving patients restless, are leveraging the demand for this market.
Parenteral nutrition (PN) is a technique providing essential nutrients to the bloodstream directly via vein. This acts as a saviour for the patients seeking immediate nutrients to support their immune system, who are struggling to swallow or absorb nutrients. The partial and total PN are two types of parenteral nutrition that effectively deliver the required nourishment as per the severity of the patients’ condition.
Mostly, doctors suggest PN when the GI tract needs 100% rest to recover, or is non-functional or disabled. The rich minerals, vitamins, amino acids, lipid emulsions, dextrose, water, and salts are the perfect blend that makes PN formula worth approaching the healthcare sector as a growing business or valuable requirement. The home parenteral nutrition is gaining more profit due to home care dominance in the healthcare sector.
The popular multi-chamber bag technology is a boost for this market. The impressive mergers and acquisitions since last year, starting with H.I.G. Capital and ITH Group, and heavy demand for customization are stimulating the growth of the parenteral nutrition market. The pharmaceutical leaders are gaining massive profits from the acquisitions, turning into local regional specialists.
They contribute to this market and lead expansion with their long-standing vision. The growing geriatric and pediatric population is attracting more business value to the parenteral nutrition industry. Alongside the strategy of big firms joining hands with small firms for assessment of quality and safety standards, they are promoting efficiency in this market line.
| Regions | Shares (%) |
| North America | 34% |
| Asia Pacific | 26% |
| Europe | 27% |
| LAMEA | 13% |
| Segments | Shares (%) |
| Carbohydrates | 28% |
| Parenteral Lipid Emulsion | 22% |
| Single Dose Amino Acid Solution | 20% |
| Trace Elements | 12% |
| Vitamins & Minerals | 18% |
| Segments | Shares (%) |
| Adult | 72% |
| Pediatrics | 28% |
| Segments | Shares (%) |
| Online | 18% |
| Retail | 32% |
| Institutional | 50% |
Published by Deepa Pandey
Related Reports
